This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0307U only for Invitae PCM MRD Monitoring from Invitae Corporation. The test evaluates a patient blood specimen for circulating tumor DNA (ctDNA) related to the patient’s tumor profile identified in a prior test (0306U). Clinicians may use the test to identify the presence of cancer cells following treatment (minimal residual disease, or MRD) and to monitor patients for cancer recurrence.
For clinical responsibility, terminology, tips and additional info
start codify free trial.